Zdrowie i gospodarka · 22/10/2019
FDA Clears Midodrine Hydrochloride Tablets for Approval
The FDA has determined that PROAMATINE tablets, 2.5mg, 5mg, and 10mg, were not withdrawn from sale due to safety or effectiveness concerns. This decision enables the FDA to approve midodrine hydrochloride tablets, 2.5mg, 5mg, and 10mg, if all applicable regulations are met.
Source: Federal Register — Food and Drug AdministrationOpen original release →